Gastric and Enteric Involvement in Progressive Systemic Sclerosis

Abstract

Progressive systemic sclerosis (PSS) is a chronic multisystem disease characterized by excess deposition of connective tissue in skin and internal organs, associated with microvasculature changes and immunologic abnormalities. Involvement of the gastrointestinal tract may occur in 2 stages, a neuropathic disorder followed by a myopathy. Gastric emptying is delayed in 10% to 75% of patients and correlates with symptoms of early satiety, bloating, and emesis. Compliance of the fundus is increased although perception of fullness is normal. Myoelectric abnormalities have been found in some studies. Treatments include metoclopramide, cisapride, and erythromycin. Bleeding from telangiectasias and watermelon stomach is treated endoscopically. Small bowel involvement in PSS occurs in 17% to 57% of patients. The migrating motor complexes are reduced or absent, predisposing to bacterial overgrowth. Malabsorption may also be due to pancreatic insufficiency. Barium enemas demonstrate pancolonic involvement in 10% to 50% of patients with PSS. Wide-mouthed diverticuli, involving all layers of the intestinal wall, are characteristic. Pseudoobstruction may respond to octreotide or prucalopride therapy. Complications include pneumatosis cystoides intestinalis, stercoral ulcerations, and perforation. Fecal incontinence may be due to dysfunction of the internal anal sphincter, a smooth muscle responsible for most of the resting anal sphincter pressure. Anal manometry may show a reduction or loss of the rectoanal inhibitory reflex. Treatments include biofeedback, sacral nerve stimulation, and surgery. PSS involves the gastrointestinal tract from the mouth to the anus. Studies are needed to define effective treatments in these diseases, which cause great morbidity.

Severe Cryptogenic Multifocal Ulcerous Stenosing Enteritis. A Report of Three Cases and Review of the Literature

“…Any type of vasculitis of any cause, if found, should be assigned simply as "vasculitis" not CMUSE. Small intestinal involvement can be found in Churg-Strauss syndrome (20,27,36), systemic lupus erythematosus (43), Buerger's disease (30), Wegener's granulomatosis (11), Weber-Christian disease (28) and systemic sclerosis (13). Vasculitis could be associated with multiple small intestinal ulcers and their complications (including perforation) but quite rarely with multifocal stenoses of the small bowel.…”

Gastrointestinal Manifestations of Scleroderma: Recent Progress in Evaluation, Pathogenesis, and Management

“…Contractile activity of the GI tract is controlled predominantly by intrinsic neurons in the myenteric plexus. Acetylcholine, acting predominantly via the M3R, is the principal excitatory neurotransmitter regulating GI tract motility and causes smooth muscle cell contraction [23]. Antibodies blocking M3R therefore would be expected to inhibit this excitatory neurotransmission and cause dysmotility.…”

Current views on the etiopathogenesis, clinical manifestation, diagnostics, treatment and correlation with other nosological entities of SIBO

“…SIBO eradication was obtained in 73.3% of the patients and a significant reduction in symptoms was observed in 72.7% [16]. It seems that the observations may be coincident with other gastrointestinal pathologies in systemic scleroderma [17]. There are also cases of maculopapular rashes, muscular and joint pain with phytobezoar and presumably SIBO [18].…”